Home/Filings/4/0001601830-24-000031
4//SEC Filing

Li Dean Y 4

Accession 0001601830-24-000031

CIK 0001601830other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 5:43 PM ET

Size

7.1 KB

Accession

0001601830-24-000031

Insider Transaction Report

Form 4
Period: 2024-04-01
Li Dean Y
Director
Transactions
  • Award

    Class A Common Stock

    2024-04-01+1,26759,089 total
Holdings
  • Class A Common Stock

    (indirect: By Trust)
    1,422,048
  • Class A Common Stock

    (indirect: By Dean Y. Li GRAT)
    1,269,796
  • Class A Common Stock

    (indirect: By Trust)
    421,000
Footnotes (2)
  • [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.
  • [F2]The reporting person is the sole trustee for this GRAT. Shares transferred by the reporting person to the GRAT on March 5, 2024.

Issuer

RECURSION PHARMACEUTICALS, INC.

CIK 0001601830

Entity typeother

Related Parties

1
  • filerCIK 0001837016

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 5:43 PM ET
Size
7.1 KB